India to Saudi Arabia: Dapagliflozin Export Trade Route
India has recorded 25 verified shipments of Dapagliflozin exported to Saudi Arabia, representing a combined trade value of $1.2M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $47.0K USD. The leading Indian exporter is AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED, which accounts for 55% of total export value with 3 shipments worth $650.9K USD. On the buying side, PHARMA PHARMACEUTICAL INDUSTRIES P is the largest importer in Saudi Arabia with $406.8K USD in purchases. The top 3 suppliers — AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Saudi Arabia Dapagliflozin corridor is one of India's established pharmaceutical export routes, with 25 shipments documented worth a combined $1.2M USD. The route is dominated by AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's dapagliflozin manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $47.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 33.8%, placing it at rank #13 among India's top dapagliflozin export destinations globally.
On the import side, key buyers of Indian dapagliflozin in Saudi Arabia include PHARMA PHARMACEUTICAL INDUSTRIES P, PHARMA PHARMACEUTICAL INDUSTRIES (P, SUDAIR PHARMA COMPANY and 6 others. PHARMA PHARMACEUTICAL INDUSTRIES P is the single largest importer with 1 shipments valued at $406.8K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portHyderabad Air
Market Position
- Global rank#13
- Annual growth+33.8%
- Demand growth+29.9%
- Regulatory ease66/100
Top 10 Indian Dapagliflozin Exporters to Saudi Arabia
Showing top 10 of 5 Indian suppliers exporting Dapagliflozin to Saudi Arabia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED Avg $217.0K per shipment | 3 | $650.9K | 55.4% |
| 2 | MSN LABORATORIES PRIVATE LIMITED Avg $58.8K per shipment | 4 | $235.4K | 20.0% |
| 3 | HETERO LABS LIMITED Avg $18.8K per shipment | 9 | $169.3K | 14.4% |
| 4 | HETERO LABS LIMITED Avg $20.0K per shipment | 6 | $120.0K | 10.2% |
| 5 | INVENTIA HEALTHCARE LIMITED Avg $1 per shipment | 3 | $2 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting dapagliflozin to Saudi Arabia, ranked by total trade value. The listed exporters are: AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED, HETERO LABS LIMITED, INVENTIA HEALTHCARE LIMITED. AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED is the dominant supplier with 3 shipments worth $650.9K USD, giving it a 55% market share. The top 3 suppliers together account for 90% of the total trade value on this route.
Top 10 Dapagliflozin Importers in Saudi Arabia
Showing top 10 of 9 known buyers in Saudi Arabia receiving Dapagliflozin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dapagliflozin in Saudi Arabia include PHARMA PHARMACEUTICAL INDUSTRIES P, PHARMA PHARMACEUTICAL INDUSTRIES (P, SUDAIR PHARMA COMPANY, TO THE ORDER OF, SAUDI AMAROX FOR INDUSTRY COMPANY, among 9 total buyers. The largest importer is PHARMA PHARMACEUTICAL INDUSTRIES P, accounting for $406.8K USD across 1 shipments — representing 35% of all dapagliflozin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA PHARMACEUTICAL INDUSTRIES P | 1 | $406.8K | 34.6% |
| 2 | PHARMA PHARMACEUTICAL INDUSTRIES (P | 2 | $244.1K | 20.8% |
| 3 | SUDAIR PHARMA COMPANY | 4 | $235.4K | 20.0% |
| 4 | TO THE ORDER OF | 5 | $101.8K | 8.7% |
| 5 | SAUDI AMAROX FOR INDUSTRY COMPANY | 5 | $89.4K | 7.6% |
| 6 | M S TO THE ORDER OFSAUDI AMAROX FOR INDUSTRY | 3 | $39.2K | 3.3% |
| 7 | TO THE ORDER OF., | 1 | $30.6K | 2.6% |
| 8 | TO THE ORDER | 1 | $28.3K | 2.4% |
| 9 | TO, | 3 | $2 | 0.0% |
Top 10 Dapagliflozin Formulations Imported by Saudi Arabia
Showing top 10 of 18 product formulations shipped on the India to Saudi Arabia Dapagliflozin route, ranked by trade value
Saudi Arabia imports a wide range of dapagliflozin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Dapagliflozin Tablets 10mg PAFAZIN 10MG 150 S — accounts for $406.8K USD across 1 shipments. There are 18 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Dapagliflozin Tablets 10mg PAFAZIN 10MG 150 S | 1 | $406.8K | 34.6% |
| 2 | DAPAGLIFLOZIN 10MG 60x10 SUDAIR SA | 3 | $213.7K | 18.2% |
| 3 | Pafazin 10mg 150'S (Dapagliflozin) | 1 | $188.8K | 16.1% |
| 4 | DAPXIGA 10MG DAPAGLIFLOZIN 10MG TABS 22 120 PACKS OF 30 s TABLETS EACH AS PERINVOICE | 2 | $82.3K | 7.0% |
| 5 | DAPXIGA DAPAGLIFLOZIN TABLET | 4 | $63.3K | 5.4% |
| 6 | Pafazin 5mg 150'S (Dapagliflozin) | 1 | $55.3K | 4.7% |
| 7 | DAPXIGA (DAPAGLIFLOZIN 10MG TABLET) | 1 | $28.7K | 2.4% |
| 8 | DAPXIGA DAPAGLIFLOZIN TABLET | 1 | $28.3K | 2.4% |
| 9 | DAPXIGA 10MG DAPAGLIFLOZIN 10MG TABS 13888 Packs Pack of 30 's | 1 | $27.4K | 2.3% |
| 10 | DAPXIGA DAPAGLIFLOZIN 10MG TABLET 10S | 1 | $27.0K | 2.3% |
Showing top 10 of 18 Dapagliflozin formulations imported by Saudi Arabia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
Hyderabad Air handles the highest volume with 4 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's dapagliflozin exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED — together account for 90% of total trade value on this route. The average shipment value of $47.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as dapagliflozin 10mg 60x10 sudair sa and pafazin 10mg 150's (dapagliflozin), suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, PHARMA PHARMACEUTICAL INDUSTRIES P is the largest importer with 1 shipments worth $406.8K USD — representing 35% of all dapagliflozin imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.2M
- Avg. Shipment
- $47.0K
- Suppliers
- 5
- Buyers
- 9
- Transit (Sea)
- ~16 days
- Annual Growth
- +33.8%
Related Analysis
Other Dapagliflozin Routes
Unlock the Full India to Saudi Arabia Dapagliflozin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 25 shipments on this route.
Frequently Asked Questions — India to Saudi Arabia Dapagliflozin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dapagliflozin to Saudi Arabia?
The leading Indian exporters of Dapagliflozin to Saudi Arabia are AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED. AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED holds the largest market share at approximately 55% of total trade value on this route.
Q What is the total value of Dapagliflozin exports from India to Saudi Arabia?
India exports Dapagliflozin to Saudi Arabia worth approximately $1.2M USD across 25 recorded shipments. The average value per shipment is $47.0K USD.
Q Which ports does India use to ship Dapagliflozin to Saudi Arabia?
The most active port of origin is Hyderabad Air with 4 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Saudi Arabia for Dapagliflozin?
The average transit time for Dapagliflozin shipments from India to Saudi Arabia is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Saudi Arabia Dapagliflozin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 33.8% with demand growth tracking at 29.9%. The route is ranked #13 among India's top Dapagliflozin export destinations globally.
Q How many suppliers are active on the India to Saudi Arabia Dapagliflozin route?
There are currently 5 active Indian suppliers exporting Dapagliflozin to Saudi Arabia. The market is moderately concentrated with AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED accounting for 55% of total shipment value.
Q Who are the main importers of Dapagliflozin from India in Saudi Arabia?
The leading importers of Indian Dapagliflozin in Saudi Arabia include PHARMA PHARMACEUTICAL INDUSTRIES P, PHARMA PHARMACEUTICAL INDUSTRIES (P, SUDAIR PHARMA COMPANY, TO THE ORDER OF, SAUDI AMAROX FOR INDUSTRY COMPANY. PHARMA PHARMACEUTICAL INDUSTRIES P is the largest buyer with 1 shipments worth $406.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Saudi Arabia export trade corridor identified from Indian Customs (DGFT) records for Dapagliflozin.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 9 importers in Saudi Arabia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 25 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
25 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists